Literature DB >> 23849601

Interrogating the relationship between naïve and immune antiviral T cell repertoires.

Nicole L La Gruta1, Paul G Thomas.   

Abstract

Understanding how naïve virus-specific CD8+ T cells influence the type of immune response generated after virus infection is critical for the development of enhanced therapeutic and vaccination strategies to exploit CD8+ T cell-mediated immunity. Recent technological advances in T cell isolation and T receptor sequencing have allowed for greater understanding of the basic structure of immune T cell repertoires, the diversity of responses within and between individuals, and changes in repertoires over time and in response to infection conditions. In this review, we discuss the current understanding of how T cell repertoires contribute to potent antiviral responses. Additionally we compare the state of the art in receptor sequencing, highlighting the advantages and disadvantages of the three most common approaches: next-generation sequencing, template-switch anchored RT-PCR, and multiplex single cell PCR. Finally, we describe how TCR sequencing has delineated the relationship between naïve and immune T cell repertoires.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23849601      PMCID: PMC3779657          DOI: 10.1016/j.coviro.2013.06.011

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  38 in total

1.  Selective activation and expansion of high-affinity CD4+ T cells in resistant mice upon infection with Leishmania major.

Authors:  L Malherbe; C Filippi; V Julia; G Foucras; M Moro; H Appel; K Wucherpfennig; J C Guéry; N Glaichenhaus
Journal:  Immunity       Date:  2000-12       Impact factor: 31.745

2.  Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity.

Authors:  Markus Cornberg; Alex T Chen; Lee A Wilkinson; Michael A Brehm; Sung-Kwon Kim; Claudia Calcagno; Dario Ghersi; Roberto Puzone; Franco Celada; Raymond M Welsh; Liisa K Selin
Journal:  J Clin Invest       Date:  2006-04-13       Impact factor: 14.808

Review 3.  Structural determinants of T-cell receptor bias in immunity.

Authors:  Stephen J Turner; Peter C Doherty; James McCluskey; Jamie Rossjohn
Journal:  Nat Rev Immunol       Date:  2006-11-17       Impact factor: 53.106

4.  Comprehensive analysis of the functional TCR repertoire at the single-cell level.

Authors:  Tatsuhiko Ozawa; Kazuto Tajiri; Hiroyuki Kishi; Atsushi Muraguchi
Journal:  Biochem Biophys Res Commun       Date:  2008-01-11       Impact factor: 3.575

5.  Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude.

Authors:  James J Moon; H Hamlet Chu; Marion Pepper; Stephen J McSorley; Stephen C Jameson; Ross M Kedl; Marc K Jenkins
Journal:  Immunity       Date:  2007-08-16       Impact factor: 31.745

6.  Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes.

Authors:  Xu G Yu; Mathias Lichterfeld; Senica Chetty; Katie L Williams; Stanley K Mui; Toshiyuki Miura; Nicole Frahm; Margaret E Feeney; Yanhua Tang; Florencia Pereyra; Montiago X Labute; Katja Pfafferott; Alisdair Leslie; Hayley Crawford; Rachel Allgaier; William Hildebrand; Richard Kaslow; Christian Brander; Todd M Allen; Eric S Rosenberg; Photini Kiepiela; Madhu Vajpayee; Paul A Goepfert; Marcus Altfeld; Philip J R Goulder; Bruce D Walker
Journal:  J Virol       Date:  2006-11-22       Impact factor: 5.103

7.  Vaccine adjuvants alter TCR-based selection thresholds.

Authors:  Laurent Malherbe; Linda Mark; Nicolas Fazilleau; Louise J McHeyzer-Williams; Michael G McHeyzer-Williams
Journal:  Immunity       Date:  2008-05-01       Impact factor: 31.745

Review 8.  T-cell receptor bias and immunity.

Authors:  Stephanie Gras; Lars Kjer-Nielsen; Scott R Burrows; James McCluskey; Jamie Rossjohn
Journal:  Curr Opin Immunol       Date:  2008-01-18       Impact factor: 7.486

9.  Strong TCR conservation and altered T cell cross-reactivity characterize a B*57-restricted immune response in HIV-1 infection.

Authors:  Geraldine M A Gillespie; Guillaume Stewart-Jones; Jaya Rengasamy; Tara Beattie; Job J Bwayo; Francis A Plummer; Rupert Kaul; Andrew J McMichael; Philippa Easterbrook; Tao Dong; E Yvonne Jones; Sarah L Rowland-Jones
Journal:  J Immunol       Date:  2006-09-15       Impact factor: 5.422

10.  Complete but curtailed T-cell response to very low-affinity antigen.

Authors:  Dietmar Zehn; Sarah Y Lee; Michael J Bevan
Journal:  Nature       Date:  2009-01-28       Impact factor: 49.962

View more
  11 in total

1.  TCRβ repertoire of CD4+ and CD8+ T cells is distinct in richness, distribution, and CDR3 amino acid composition.

Authors:  Hoi Ming Li; Toyoko Hiroi; Yongqing Zhang; Alvin Shi; Guobing Chen; Supriyo De; E Jeffrey Metter; William H Wood; Alexei Sharov; Joshua D Milner; Kevin G Becker; Ming Zhan; Nan-ping Weng
Journal:  J Leukoc Biol       Date:  2015-09-22       Impact factor: 4.962

2.  Sequence and Structural Analyses Reveal Distinct and Highly Diverse Human CD8+ TCR Repertoires to Immunodominant Viral Antigens.

Authors:  Guobing Chen; Xinbo Yang; Annette Ko; Xiaoping Sun; Mingming Gao; Yongqing Zhang; Alvin Shi; Roy A Mariuzza; Nan-Ping Weng
Journal:  Cell Rep       Date:  2017-04-18       Impact factor: 9.423

3.  Structural Basis for Clonal Diversity of the Public T Cell Response to a Dominant Human Cytomegalovirus Epitope.

Authors:  Xinbo Yang; Mingming Gao; Guobing Chen; Brian G Pierce; Jinghua Lu; Nan-Ping Weng; Roy A Mariuzza
Journal:  J Biol Chem       Date:  2015-10-01       Impact factor: 5.157

4.  Structural basis for clonal diversity of the human T-cell response to a dominant influenza virus epitope.

Authors:  Xinbo Yang; Guobing Chen; Nan-Ping Weng; Roy A Mariuzza
Journal:  J Biol Chem       Date:  2017-09-20       Impact factor: 5.157

5.  Paired TCRαβ analysis of virus-specific CD8(+) T cells exposes diversity in a previously defined 'narrow' repertoire.

Authors:  Tania Cukalac; Wan-Ting Kan; Pradyot Dash; Jing Guan; Kylie M Quinn; Stephanie Gras; Paul G Thomas; Nicole L La Gruta
Journal:  Immunol Cell Biol       Date:  2015-03-25       Impact factor: 5.126

6.  Diversification of the antigen-specific T cell receptor repertoire after varicella zoster vaccination.

Authors:  Qian Qi; Mary M Cavanagh; Sabine Le Saux; Hong NamKoong; Chulwoo Kim; Emerson Turgano; Yi Liu; Chen Wang; Sally Mackey; Gary E Swan; Cornelia L Dekker; Richard A Olshen; Scott D Boyd; Cornelia M Weyand; Lu Tian; Jörg J Goronzy
Journal:  Sci Transl Med       Date:  2016-03-30       Impact factor: 17.956

Review 7.  Beyond model antigens: high-dimensional methods for the analysis of antigen-specific T cells.

Authors:  Evan W Newell; Mark M Davis
Journal:  Nat Biotechnol       Date:  2014-01-19       Impact factor: 54.908

8.  Clinical, immunological and treatment-related factors associated with normalised CD4+/CD8+ T-cell ratio: effect of naïve and memory T-cell subsets.

Authors:  Willard Tinago; Elizabeth Coghlan; Alan Macken; Julie McAndrews; Brenda Doak; Charlotte Prior-Fuller; John S Lambert; Gerard J Sheehan; Patrick W G Mallon
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

9.  Enhancement of Macrophage Function by the Antimicrobial Peptide Sublancin Protects Mice from Methicillin-Resistant Staphylococcus aureus.

Authors:  Shuai Wang; Qianhong Ye; Ke Wang; Xiangfang Zeng; Shuo Huang; Haitao Yu; Qing Ge; Desheng Qi; Shiyan Qiao
Journal:  J Immunol Res       Date:  2019-09-08       Impact factor: 4.818

10.  Interferon lambda rs368234815 ΔG/ΔG is associated with higher CD4+:CD8+ T-cell ratio in treated HIV-1 infection.

Authors:  Inês T Freitas; Willard Tinago; Hirofumi Sawa; Julie McAndrews; Brenda Doak; Charlotte Prior-Fuller; Gerard Sheehan; John S Lambert; Eavan Muldoon; Aoife G Cotter; William W Hall; Patrick W G Mallon; Michael J Carr
Journal:  AIDS Res Ther       Date:  2020-04-15       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.